Skip to main content
. 2018 Jun 14;41(7):1526–1534. doi: 10.2337/dc17-2222

Table 1.

Characteristics of participants (n = 17,272) and studies (n = 63) included in meta-analyses

Value
Baseline participant-level characteristics*
Age, years 49.7 (7.9)
Male 28.8%
White/European 60.8%
Pacific Islander/Indigenous 29.7%
Asian 10.6%
Weight, kg 85.0 (11.0)
BMI, kg/m2 31.3 (4.2)
FBG, mmol/L 5.7 (0.6)
2-h PPG, mmol/L 6.4 (1.7)
A1C, % 5.6 (0.5)
A1C, mmol/mol
37.7
Study-level characteristics
Country of study
 U.S. 41 (65)
 U.K. 5 (8)
 Australia 4 (6)
 New Zealand 3 (5)
 The Netherlands 2 (3)
 Finland 2 (3)
 Canada, Greece, Israel, Japan, Spain, and Norway (one each) 6 (10)
Design
 Pre/post single group study 25 (40)
 Nonrandomized controlled study 16 (25)
 Randomized controlled study 22 (35)
Intervention strategy
 Group diabetes education from community member 28 (44)
 Group diabetes education from health care professional 31 (49)
 Individual counseling from health care professional 4 (6)
 Education/counseling delivered using technology 8 (13)
Delivery Setting
 Remote delivery 8 (13)
 Community setting 39 (62)
 Clinical setting 25 (40)
Provider Type
 Lay community member 28 (44)
 Health care professional 33 (52)
 Technology assisted 7 (11)

Data are mean or mean (SD) for participant-level characteristics, unless otherwise noted, and n (%) for study-level characteristics. Individual study characteristics are presented in Supplementary Table 1.

*Baseline participant-level characteristics are weighted averages by the number of participants in each study.

†Some studies used more than one of these strategies/setting/provider, which makes the study count go over 63.

‡Technologies used to provide group/individual education or counseling include interactive voice response calls, video conference, internet, cable television, and DVDs.